CME Group posts strong earnings on growing trading volumes and margins. Learn the risks, market opportunities, and why it's ...

CME Group is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key ...

CME Group will release its second-quarter earnings later this month, and analysts anticipate a double-digit bottom-line ...

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. CME Group Cl ACME just hit that mark ...

CME Group's Financial Performance Revenue Growth: Over the 3 months period, CME Group showcased positive performance, achieving a revenue growth rate of 10.38% as of 31 March, 2025.

Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization. CME Group: Financial Performance Dissected ...

CME Group: Financial Performance Dissected Revenue Growth: CME Group displayed positive results in 3 months. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately ...

CME's historical dominance is underpinned by a legacy of product launches dating back to the 1800s, and its stock has dramatically outperformed the S&P 500 since its 2002 IPO, delivering a 20% CAGR.

KKR shares have fallen 9% year-to-date, underperforming the alternative asset manager group, which is down 2%, and the S&P ...

Director William R. Shepard of CME Group Inc (NASDAQ: CME) recently purchased company stock in two transactions valued at $72,336.

Director William R. Shepard of CME Group Inc (NASDAQ: CME) recently purchased company stock in two transactions valued at $72,336. According to a Form 4 filing with the Securities and Exchange ...